Advanced search×

Temporal lobe epilepsy in children: etiology in a cohort with new-onset seizures.

László L Sztriha, Aithala K AK Gururaj, Abdulbari A Bener, and Michael M Nork

Epilepsia 43(1):75-80 (2002) PMID 11879390

The aim of this study was to characterize the incidence and etiology of temporal lobe epilepsy (TLE) in a community-based cohort of children with new-onset disease.

DOI: 10.1046/j.1528-1157.2002.24201.x
Version: za2963e q8za6 q8zba q8zcb q8zd0 q8ze3 q8zf9 q8zgb

Similar articles you may find interesting…

  1. Abating progressive tissue injury and preserving function after CNS trauma: The role of inflammation modulatory therapies.
    Damien D Pearse and Kurt K Jarnagin

    Curr Opin Investig Drugs 11(11):1207-10 (2010) PMID 21189657

    Brain and spinal cord injuries result in cognitive and/or sensorimotor impairments that can significantly diminish the quality of life for the patient and their carers, and result in healthcare system costs totaling in the billions. The current gold-standard of acute care for spinal cord injury is t...
  2. Development in the cynomolgus macaque following administration of ustekinumab, a human anti-IL-12/23p40 monoclonal antibody, during pregnanc...
    Pauline L PL Martin, Clifford C Sachs, ... George G Treacy

    Birth Defects Res B Dev Reprod Toxicol 89(5):351-63 (2010) PMID 20540088

    Ustekinumab is a human monoclonal antibody that binds to the p40 subunit of interleukin (IL) 12 and IL-23 and inhibits their pharmacological activity. To evaluate potential effects of ustekinumab treatment during pregnancy, developmental studies were conducted in cynomolgus macaques....
  3. Exemestane for breast-cancer prevention in postmenopausal women.
    Paul E Goss, James N Ingle, ... Harriet Richardson

    N Engl J Med 364(25):2381-91 (2011) PMID 21639806

    Estrogens contribute to normal breast development but can also promote breast cancer in preclinical models and in women with high circulating plasma estrogen levels.1–4 To date, chemoprevention of breast cancer has focused on the selective estrogen-receptor modulators (SERMs) tamoxifen and raloxife...